Complete Filing Data
Crown PropTech Acquisitions reported Stockholders Equity of -$5.30 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Crown PropTech Acquisitions did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$3.0M | -$204.5K | $523.5K | $14.8M | $6.7M |
| Nonoperating Income Expense | $11.1K | $496.0K | $2.6M | $19.0M | $12.3M |
| Operating Income Loss | -$3.0M | -$700.5K | -$2.1M | -$4.2M | -$5.6M |
| Net Income Loss Attributable To Nonredeemable Noncontrolling Interest | $523.5K | $14.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$187.2K | -$1.2M | -$712.1K | -$161.2K | $235.5K | -$333.5K | $950.7K | $860.2K | -$2.0M | $1.8M | $212.8K | $3.4M | $3.9M | -$1.5M | $9.6M | -$5.9K |
| Nonoperating Income Expense | $94.2K | -$199.2K | $60.7K | $99.4K | $281.2K | $49.0K | $1.4M | $1.2M | -$837.8K | $2.3M | $2.5M | $4.6M | $4.4M | -$991.1K | $9.7M | |
| Operating Income Loss | -$281.4K | -$772.8K | -$260.6K | -$45.7K | -$382.6K | -$400.1K | -$317.5K | -$1.2M | -$485.7K | -$2.3M | -$1.2M | -$513.7K | -$481.2K | -$126.3K | -$6.0K | |
| Net Income Loss Attributable To Nonredeemable Noncontrolling Interest | $950.7K | $860.2K | -$255.9K | $1.8M | $212.8K | $3.4M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | -$5.3M | -$3.0M | -$2.3M | -$1.5M | -$21.9M | $19.1K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $425.00 | $425.00 | $652.00 | $80.2K | $14.8K | $72.6K |
| Retained Earnings Accumulated Deficit | -$18.3M | -$15.0M | -$13.9M | -$11.0M | -$21.9M | -$5.9K |
| Liabilities | $5.3M | $3.0M | $2.3M | $1.6M | $21.9M | $255.0K |
| Liabilities Current | $5.3M | $3.0M | $2.3M | $1.6M | $4.2M | $255.0K |
| Liabilities And Stockholders Equity | $5.8M | $5.8M | $45.1M | $280.1M | $276.1M | $274.1K |
| Assets Current | $1.4K | $2.0K | $3.5K | $119.8K | $90.7K | $274.1K |
| Assets | $5.8M | $5.8M | $45.1M | $280.1M | $276.1M | $274.1K |
| Assets Held In Trust Noncurrent | $5.8M | $5.8M | $45.1M | $280.0M | $276.0M | |
| Temporary Equity Carrying Amount Attributable To Parent | $45.1M | $280.0M | $276.0M | |||
| Temporary Equity Accretion To Redemption Value | $234.2K | $947.3K | $3.4M | $4.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$79.6K | $65.4K | -$57.7K | |||
| Accounts Payable And Accrued Liabilities Current And Noncurrent | $3.6M | $180.0K | ||||
| Cash And Cash Equivalents At Carrying Value | $14.8K | $72.6K | ||||
| Temporary Equity Accretion To Redemption Value Adjustment | $4.0M | $29.4M | ||||
| Accounts Payable And Accrued Liabilities Current | $3.7M | $1.8M | $1.4M | $627.4K | ||
| Notes Payable Related Parties Classified Current | $159.1K | |||||
| Change In Fair Value Of Warrant Liabilities | -$8.1M | -$13.1M | ||||
| Settlement Of Payables And Due To Related Party | -$420.5K | -$6.5M | ||||
| Settlement Of Payables | $420.5K | -$6.5M | ||||
| Deferred Underwriting Compensation Noncurrent | $0.00 | $9.7M | ||||
| Repayments Of Related Party Debt | $75.0K | |||||
| Initial Fair Value Of Warrant Liabilities | $21.2M | |||||
| Initial Classification Of Common Stock Subject To Possible Redemption | $246.6M | |||||
| Deferred Underwriting Fee Payable | $9.7M | |||||
| Convertible Notes Payable Current | $666.0K | $450.0K | ||||
| Equity Contribution From Previous Sponsor In Connection With The Securities Assignment Agreement | $263.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$227.00 | -$79.6K | ||||
| Deferred Offering Costs | $201.6K | |||||
| Preferred Stock Value | $0.00 | |||||
| Common Stock Subject To Possible Redemption Value |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$4.9M | -$4.8M | -$3.8M | -$3.0M | -$2.7M | -$2.7M | -$2.4M | -$2.8M | -$3.5M | -$18.0M | -$18.7M | -$18.5M | -$16.5M | -$20.4M | -$19.0M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $425.00 | $425.00 | $425.00 | $425.00 | $425.00 | $425.00 | $1.1K | $31.0K | $1.4K | $616.00 | $4.6K | $38.5K | $277.7K | $622.4K | $775.7K | |||
| Retained Earnings Accumulated Deficit | -$17.3M | -$17.1M | -$15.8M | -$15.0M | -$14.7M | -$14.6M | -$14.0M | -$14.4M | -$14.8M | -$18.1M | -$18.7M | -$18.5M | -$16.5M | -$20.4M | -$19.0M | |||
| Liabilities | $5.0M | $4.8M | $3.8M | $3.0M | $2.7M | $2.7M | $2.4M | $2.9M | $3.5M | $18.2M | $18.9M | $18.9M | $17.1M | $21.5M | $20.3M | |||
| Liabilities Current | $5.0M | $4.8M | $3.8M | $3.0M | $2.7M | $2.7M | $2.1M | $1.7M | $2.0M | $8.1M | $7.8M | $5.6M | $164.9K | $174.9K | $24.1K | |||
| Liabilities And Stockholders Equity | $5.8M | $5.7M | $5.9M | $5.7M | $22.1M | $21.8M | $44.5M | $44.0M | $43.4M | $277.8M | $276.7M | $276.4M | $276.5M | $277.1M | $277.4M | |||
| Assets Current | $82.7K | $4.6K | $6.1K | $4.8K | $7.8K | $10.7K | $27.3K | $67.7K | $1.4K | $132.3K | $228.2K | $344.0K | $532.7K | $1.1M | $1.4M | |||
| Assets | $5.8M | $5.7M | $5.9M | $5.7M | $22.1M | $21.8M | $44.5M | $44.0M | $43.4M | $277.8M | $276.7M | $276.4M | $276.5M | $277.1M | $277.4M | |||
| Assets Held In Trust Noncurrent | $5.7M | $5.7M | $5.9M | $5.7M | $22.0M | $21.8M | $44.5M | $43.9M | $43.4M | $277.7M | $276.4M | $276.0M | $276.0M | $276.0M | $276.0M | |||
| Temporary Equity Carrying Amount Attributable To Parent | $5.7M | $5.7M | $5.9M | $5.8M | $5.7M | $22.0M | $21.8M | $44.5M | $43.9M | $43.4M | $277.7M | $276.4M | $276.0M | $241.6M | ||||
| Temporary Equity Accretion To Redemption Value | $58.7K | $59.4K | $60.7K | $174.7K | $281.2K | $425.0K | $569.0K | $511.7K | $1.7M | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$227.00 | -$78.8K | $23.7K | $703.2K | $72.6K | |||||||||||||
| Accounts Payable And Accrued Liabilities Current And Noncurrent | $925.3K | $1.2M | $627.4K | $7.4M | $7.1M | $5.0M | $50.8K | $150.8K | $1.1M | |||||||||
| Cash And Cash Equivalents At Carrying Value | $31.0K | $1.4K | $80.2K | $616.00 | $4.6K | $38.5K | $277.7K | $622.4K | $775.7K | |||||||||
| Temporary Equity Accretion To Redemption Value Adjustment | -$569.0K | -$511.7K | -$1.7M | -$1.2M | -$392.0K | -$22.5K | $28.6M | |||||||||||
| Accounts Payable And Accrued Liabilities Current | $3.4M | $3.3M | $2.5M | $1.8M | $1.6M | $1.6M | $1.2M | |||||||||||
| Notes Payable Related Parties Classified Current | $0.00 | $339.1K | $294.1K | $249.1K | $204.1K | $114.1K | $24.1K | $24.1K | ||||||||||
| Change In Fair Value Of Warrant Liabilities | -$284.3K | $1.4M | -$1.1M | -$2.1M | -$4.5M | -$4.4M | $994.9K | |||||||||||
| Settlement Of Payables And Due To Related Party | $7.3M | -$38.8K | $6.5M | |||||||||||||||
| Settlement Of Payables | $381.8K | $38.8K | ||||||||||||||||
| Deferred Underwriting Compensation Noncurrent | $9.7M | $9.7M | $9.7M | $9.7M | $9.7M | $9.7M | ||||||||||||
| Repayments Of Related Party Debt | $75.0K | |||||||||||||||||
| Initial Fair Value Of Warrant Liabilities | $21.2M | |||||||||||||||||
| Initial Classification Of Common Stock Subject To Possible Redemption | $246.6M | |||||||||||||||||
| Deferred Underwriting Fee Payable | $9.7M | |||||||||||||||||
| Convertible Notes Payable Current | $491.0K | $450.0K | $450.0K | |||||||||||||||
| Equity Contribution From Previous Sponsor In Connection With The Securities Assignment Agreement | $263.0K | |||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$227.00 | |||||||||||||||||
| Deferred Offering Costs | ||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Common Stock Subject To Possible Redemption Value | -$1.5M | $276.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.1M | -$273.9K | -$917.7K | -$498.3K | -$2.1M |
| Net Cash Provided By Used In Financing Activities | $858.7K | -$39.9M | -$237.5M | $563.7K | $278.0M |
| Increase Decrease In Prepaid Expense | -$602.00 | -$1.2K | -$36.8K | -$36.3K | $75.9K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.9M | $425.4K | $1.2M | $3.5M | $3.4M |
| Net Cash Provided By Used In Investing Activities | $250.1K | $40.2M | $238.3M | -$276.0M | |
| Proceeds From Sale Of Restricted Investments | $250.1K | $40.2M | $238.3M | ||
| Proceeds From Related Party Debt | $403.5K | $273.7K | $249.4K | $216.0K | $450.0K |
| Payments Of Redemption Of Ordinary Share Subject To Possible Redemption | $250.1K | $40.2M | $238.3M | ||
| Proceeds From Issuance Of Warrants | $7.5M | ||||
| Payments Of Stock Issuance Costs | $328.5K | ||||
| Payments For Investment Of Cash In Trust Account | $276.0M | ||||
| Proceeds From Contributed Capital | $705.2K | $325.7K | |||
| Increase Decrease In Accounts Payable |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q2 2022 | Q1 2022 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$86.1K | -$171.2K | -$484.9K | $23.7K | -$893.3K | -$27.5K | |||||
| Net Cash Provided By Used In Financing Activities | $86.1K | -$23.6M | -$237.9M | $0.00 | $277.6M | $100.0K | |||||
| Increase Decrease In Prepaid Expense | $4.1K | $7.5K | -$39.6K | $229.6K | $611.1K | ||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $690.8K | $218.8K | $652.3K | $1.4M | -$180.0K | -$21.6K | |||||
| Net Cash Provided By Used In Investing Activities | $23.7M | $238.3M | $0.00 | -$276.0M | |||||||
| Proceeds From Sale Of Restricted Investments | $16.5M | $0.00 | $23.7M | $0.00 | $0.00 | $238.3M | $0.00 | $0.00 | |||
| Proceeds From Related Party Debt | $86.1K | $171.0K | $75.0K | ||||||||
| Payments Of Redemption Of Ordinary Share Subject To Possible Redemption | $23.7M | $238.3M | |||||||||
| Proceeds From Issuance Of Warrants | $0.00 | $7.5M | |||||||||
| Payments Of Stock Issuance Costs | $328.5K | ||||||||||
| Payments For Investment Of Cash In Trust Account | $276.0M | ||||||||||
| Proceeds From Contributed Capital | $8.0K | ||||||||||
| Increase Decrease In Accounts Payable | -$180.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | ||||
| Temporary Equity Shares Outstanding |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Temporary Equity Shares Outstanding | 27.6M | 27.6M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Investment Income Dividend | $234.2K | $947.3K | $3.4M | $4.0M | $13.3K | |
| Operating Costs And Expenses | $3.0M | $700.5K | $2.1M | $4.2M | $5.6M | |
| Fair Value Adjustment Of Warrants | -$14.00 | $14.00 | -$8.1M | -$13.1M | ||
| Additional Paid In Capital | $13.0M | $12.1M | $11.6M | $9.5M | $24.3K | |
| Prepaid Expense Current | $992.00 | $1.6K | $2.8K | $39.6K | $75.9K | |
| Remeasurement Of Class Ordinary Shares Subject To Possible Redemption | 234.2K | 947.3K | 3.4M | 4.0M | 29.4M | |
| Nonredemption Agreement Expense | $223.1K | $451.3K | $1.2M | |||
| Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares | 8.1M | |||||
| Increasedecreaseinduetorelatedpartiescurrent1 | $180.0K | $159.1K | ||||
| Adjustments To Additional Paid In Capital Other | $928.4K | $451.3K | $1.2M | $9.2M | ||
| Warrants And Rights Outstanding | $14.00 | $14.00 | ||||
| Adjustments To Additional Paid In Capital Increase Capital Contribution From Sponsors | $451.3K | $325.7K | $347.7K | |||
| Trust Dividend Income Adjustments In Operating Activities | $4.0M | $13.3K | ||||
| Offering Costs Relating To Warrants Issuance | -$479.8K | $819.8K | ||||
| Net Proceeds From Initial Public Offering | $270.5M | |||||
| Formation Income Loss And Operating Costs | ||||||
| Stock Issued1 | $451.3K | $1.2M | ||||
| Interest And Dividend Income Operating | $3.4M | $4.0M | ||||
| Adjustments To Additional Paid In Capital Securities Assignment Agreement Securities Assignment Agreement | $263.0K | |||||
| Sponsor Loans | $75.0K | |||||
| Excess Fair Value Adjustments For Private Placement Warrants | $50.1K | |||||
| Units Issued During Period Value New Issues | ||||||
| Fair Value Of Warrants | ||||||
| Capital Contribution From Previous Sponsor In Connection With Forgiveness Of Administrative Services | $339.1K | |||||
| Capital Contribution From Previous Sponsor In Connection With Forgiveness Of Administrative Servic | ||||||
| Adjustments To Additional Paid In Capital Warrant Issued |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Dividend | $58.7K | $59.4K | $60.7K | $174.7K | $281.2K | $425.0K | $569.0K | $511.7K | $1.7M | $1.2M | $392.0K | $22.5K | $4.2K | $3.9K | |||
| Operating Costs And Expenses | $281.4K | $1.0M | $772.8K | $260.6K | $45.7K | $382.6K | $400.1K | $317.5K | $1.2M | $485.7K | $2.3M | $1.2M | $513.7K | $481.2K | $126.3K | $6.0K | |
| Fair Value Adjustment Of Warrants | -$35.5K | $35.5K | -$781.7K | -$284.3K | $1.4M | -$1.1M | -$4.5M | -$4.4M | $994.9K | -$10.5M | |||||||
| Additional Paid In Capital | $12.4M | $12.3M | $12.1M | $12.1M | $12.0M | $12.0M | $11.6M | $11.6M | $11.3M | $97.0K | $5.8M | ||||||
| Prepaid Expense Current | $82.3K | $4.1K | $5.7K | $4.4K | $7.4K | $10.3K | $26.1K | $36.6K | $0.00 | $131.6K | $223.7K | $305.5K | $254.9K | $434.0K | $611.1K | ||
| Remeasurement Of Class Ordinary Shares Subject To Possible Redemption | 60.7K | 425.0K | 1.7M | 22.5K | 29.4M | ||||||||||||
| Nonredemption Agreement Expense | $223.1K | $75.3K | $376.0K | $1.2M | |||||||||||||
| Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares | 1.1M | 1.4M | 0.00 | 356.8K | 1.4M | 3.6M | 7.2M | 11.7M | 10.7M | ||||||||
| Increasedecreaseinduetorelatedpartiescurrent1 | $45.0K | $24.1K | |||||||||||||||
| Adjustments To Additional Paid In Capital Other | $120.0K | $223.1K | $75.3K | $376.0K | $1.2M | ||||||||||||
| Warrants And Rights Outstanding | $35.5K | $14.00 | $14.00 | $14.00 | $14.00 | $355.3K | |||||||||||
| Adjustments To Additional Paid In Capital Increase Capital Contribution From Sponsors | $75.3K | $376.0K | $317.7K | $8.0K | $97.0K | ||||||||||||
| Trust Dividend Income Adjustments In Operating Activities | $1.7M | $22.5K | |||||||||||||||
| Offering Costs Relating To Warrants Issuance | $780.3K | ||||||||||||||||
| Net Proceeds From Initial Public Offering | $270.5M | ||||||||||||||||
| Formation Income Loss And Operating Costs | $485.7K | $2.3M | $1.2M | $513.7K | $481.2K | $126.3K | |||||||||||
| Stock Issued1 | $376.0K | $1.2M | |||||||||||||||
| Interest And Dividend Income Operating | $425.0K | $1.7M | |||||||||||||||
| Adjustments To Additional Paid In Capital Securities Assignment Agreement Securities Assignment Agreement | $263.0K | ||||||||||||||||
| Sponsor Loans | |||||||||||||||||
| Excess Fair Value Adjustments For Private Placement Warrants | $50.1K | ||||||||||||||||
| Units Issued During Period Value New Issues | $276.0M | ||||||||||||||||
| Fair Value Of Warrants | -$21.2M | ||||||||||||||||
| Capital Contribution From Previous Sponsor In Connection With Forgiveness Of Administrative Services | $339.1K | ||||||||||||||||
| Capital Contribution From Previous Sponsor In Connection With Forgiveness Of Administrative Servic | $339.1K | ||||||||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $7.5M |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.